1. Home
  2. ASTL vs OCGN Comparison

ASTL vs OCGN Comparison

Compare ASTL & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$4.38

Market Cap

467.0M

Sector

Industrials

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.62

Market Cap

387.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTL
OCGN
Founded
1902
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.0M
387.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ASTL
OCGN
Price
$4.38
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.4M
5.0M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
2.15%
N/A
EPS Growth
N/A
31.58
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4,139.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$0.52
52 Week High
$7.25
$2.00

Technical Indicators

Market Signals
Indicator
ASTL
OCGN
Relative Strength Index (RSI) 45.21 48.33
Support Level $4.14 $1.44
Resistance Level $4.64 $1.88
Average True Range (ATR) 0.28 0.16
MACD -0.04 0.01
Stochastic Oscillator 12.58 37.90

Price Performance

Historical Comparison
ASTL
OCGN

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: